Loading...
Market
Will CVS shares recover to pre-announcement levels by end of 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock market data from sources like Yahoo Finance or Bloomberg
Story
CVS Replaces CEO Karen Lynch with David Joyner as Earnings Miss; Shares Plunge 13%
Oct 18, 2024, 10:36 AM
CVS Health Corp. has appointed longtime executive David Joyner as its new President and Chief Executive Officer, replacing Karen Lynch who stepped down following a tumultuous tenure and an agreement with the board. The leadership change coincides with the company's warning of lower third-quarter earnings, citing medical cost trends exceeding prior projections, including a Medical Loss Ratio of 95% versus expectations of 91%. Preliminary Q3 adjusted earnings per share are expected to be between $1.05 and $1.10, significantly below estimates and the company's previous outlook issued in August. The healthcare giant is backing away from its 2024 guidance amid a hit to its Medicare Advantage business. Following the announcements, CVS shares sank as much as 13%, reflecting investor concerns over the company's financial performance and strategic direction.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Higher • 25%
Lower • 25%
Unchanged (+/- 5%) • 25%
Other • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Outperform • 25%
Match • 25%
Underperform • 25%
Significantly Underperform • 25%
Yes • 50%
No • 50%